Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: TO ALL READERS .. If you invested in PTSC before 2005,

S&L worked the market, and it was clearly evident in the terms that they could do this. That is why removing the convertibles was paramount. As I have repeatedly requested, what was the price at which S&L would redeem the stock?

I believe that I have answered you. The conversion price was in the fractions of pennies.

For its investment S & L was in a win/win bigger situation. And as I have said, the dividends were unconscionable and unnecessary.

Update .... you also say

I respectfully refer you to the filings on the matter.

please, go ahead

Share
New Message
Please login to post a reply